The ICR has welcomed the news that insurer Aviva and developer Socius have been announced as the preferred bidder for a major life-sciences redevelopment project at The London Cancer Hub in Sutton.

Vortex Biosciences is expanding its footprint at The London Cancer Hub’s Innovation Gateway in support of its next phase of growth, having opened a new laboratory there earlier this year.

Personalised cancer medicine start-up Curesponse has become the latest MedTech company to move in at the Innovation Gateway at The London Cancer Hub in Sutton, south London.